There were 1,560 press releases posted in the last 24 hours and 413,989 in the last 365 days.

Recent Analysis Shows TransEnterix, XOMA, Pixelworks, eGain, Mesa Laboratories, and Lantronix Market Influences — Renewed Outlook, Key Drivers of Growth

NEW YORK, April 17, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of TransEnterix, Inc. (NYSE:TRXC), XOMA Corporation (NASDAQ:XOMA), Pixelworks, Inc. (NASDAQ:PXLW), eGain Corporation (NASDAQ:EGAN), Mesa Laboratories, Inc. (NASDAQ:MLAB), and Lantronix, Inc. (NASDAQ:LTRX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

TRXC DOWNLOAD: http://Capital-Review.com/register/?so=TRXC
XOMA DOWNLOAD: http://Capital-Review.com/register/?so=XOMA
PXLW DOWNLOAD: http://Capital-Review.com/register/?so=PXLW
EGAN DOWNLOAD: http://Capital-Review.com/register/?so=EGAN
MLAB DOWNLOAD: http://Capital-Review.com/register/?so=MLAB
LTRX DOWNLOAD: http://Capital-Review.com/register/?so=LTRX

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine TransEnterix, Inc. (NYSE:TRXC), XOMA Corporation (NASDAQ:XOMA), Pixelworks, Inc. (NASDAQ:PXLW), eGain Corporation (NASDAQ:EGAN), Mesa Laboratories, Inc. (NASDAQ:MLAB), and Lantronix, Inc. (NASDAQ:LTRX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

TRANSENTERIX, INC. (TRXC) REPORT OVERVIEW

TransEnterix's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, TransEnterix reported revenue of $7.52MM vs $3.40MM (up 121.42%) and analysts estimated basic earnings per share -$0.03 vs -$0.47. For the twelve months ended December 31st, 2018 vs December 31st, 2017, TransEnterix reported revenue of $24.10MM vs $7.11MM (up 238.94%) and analysts estimated basic earnings per share -$0.30 vs -$0.97. Analysts expect earnings to be released on May 14th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.06. The estimated EPS forecast for the next fiscal year is -$0.22 and is expected to report on February 25th, 2020.

To read the full TransEnterix, Inc. (TRXC) report, download it here: http://Capital-Review.com/register/?so=TRXC

-----------------------------------------

XOMA CORPORATION (XOMA) REPORT OVERVIEW

XOMA's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, XOMA reported revenue of $1.69MM vs $5.36MM (down 68.55%) and analysts estimated basic earnings per share -$0.35 vs $1.04. For the twelve months ended December 31st, 2018 vs December 31st, 2017, XOMA reported revenue of $5.30MM vs $52.69MM (down 89.94%) and analysts estimated basic earnings per share -$1.59 vs $0.75. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.46. The estimated EPS forecast for the next fiscal year is -$1.41 and is expected to report on March 5th, 2020.

To read the full XOMA Corporation (XOMA) report, download it here: http://Capital-Review.com/register/?so=XOMA

-----------------------------------------

PIXELWORKS, INC. (PXLW) REPORT OVERVIEW

Pixelworks' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Pixelworks reported revenue of $20.54MM vs $18.45MM (up 11.33%) and analysts estimated basic earnings per share -$0.05 vs -$0.13. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Pixelworks reported revenue of $76.55MM vs $80.64MM (down 5.06%) and analysts estimated basic earnings per share -$0.13 vs -$0.13. Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.03. The estimated EPS forecast for the next fiscal year is -$0.12 and is expected to report on February 6th, 2020.

To read the full Pixelworks, Inc. (PXLW) report, download it here: http://Capital-Review.com/register/?so=PXLW

-----------------------------------------

EGAIN CORPORATION (EGAN) REPORT OVERVIEW

eGain's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, eGain reported revenue of $17.70MM vs $15.40MM (up 14.98%) and basic earnings per share $0.07 vs -$0.03. For the twelve months ended June 30th, 2018 vs June 30th, 2017, eGain reported revenue of $61.31MM vs $58.22MM (up 5.31%) and analysts estimated basic earnings per share -$0.07 vs -$0.22. Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.01. The estimated EPS forecast for the next fiscal year is $0.14 and is expected to report on September 5th, 2019.

To read the full eGain Corporation (EGAN) report, download it here: http://Capital-Review.com/register/?so=EGAN

-----------------------------------------

MESA LABORATORIES, INC. (MLAB) REPORT OVERVIEW

Mesa Laboratories' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Mesa Laboratories reported revenue of $26.68MM vs $23.67MM (up 12.72%) and analysts estimated basic earnings per share $0.22 vs -$2.93. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Mesa Laboratories reported revenue of $96.18MM vs $93.67MM (up 2.68%) and analysts estimated basic earnings per share -$0.79 vs $3.04. Analysts expect earnings to be released on June 4th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $2.18. The estimated EPS forecast for the next fiscal year is $8.35 and is expected to report on June 4th, 2019.

To read the full Mesa Laboratories, Inc. (MLAB) report, download it here: http://Capital-Review.com/register/?so=MLAB

-----------------------------------------

LANTRONIX, INC. (LTRX) REPORT OVERVIEW

Lantronix's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Lantronix reported revenue of $12.11MM vs $11.34MM (up 6.86%) and analysts estimated basic earnings per share $0.01 vs $0.01 (unchanged). For the twelve months ended June 30th, 2018 vs June 30th, 2017, Lantronix reported revenue of $45.58MM vs $44.73MM (up 1.90%) and analysts estimated basic earnings per share $0.04 vs -$0.02. Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019.

To read the full Lantronix, Inc. (LTRX) report, download it here: http://Capital-Review.com/register/?so=LTRX

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Morena Zambada, Media Department
Office: +1 (410) 280-7496
E-mail: media@Capital-Review.com

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.